Corynebacterium jeikeium: Difference between revisions
From IDWiki
Corynebacterium jeikeium
No edit summary |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
| − | * Species of [[Corynebacterium |
+ | * Species of [[Genus::Corynebacterium]] that causes opportunistic infections, most closely associated with hematologic stem cell transplant patients |
* Clinical presentations include bacteremia, prosthetic valve endocarditis, meningitis, and peritonitis |
* Clinical presentations include bacteremia, prosthetic valve endocarditis, meningitis, and peritonitis |
||
* Essentially universally susceptible to [[vancomycin]] and [[linezolid]] |
* Essentially universally susceptible to [[vancomycin]] and [[linezolid]] |
||
| + | * High rates of resistance to beta lactams; may be fluoroquinolone or tetracycline susceptible[[CiteRef::nemuchwala2018in]] |
||
| − | * High rates of resistance to beta lactams; may be fluoroquinolone or tetracycline susceptible<ref name=":0">Neemuchwala A, Soares D, Ravirajan V, Marchand-Austin A, Kus JV, Patel SN. ''In Vitro'' Antibiotic Susceptibility Pattern of Non-diphtheriae Corynebacterium Isolates in Ontario, Canada, from 2011 to 2016. Antimicrob Agents Chemother. 2018 Mar 27;62(4):e01776-17. doi: [https://doi.org/10.1128/aac.01776-17 10.1128/AAC.01776-17]. PMID: [https://pubmed.ncbi.nlm.nih.gov/29339389/ 29339389]; PMCID: [http://www.ncbi.nlm.nih.gov/pmc/articles/pmc5914010/ PMC5914010].</ref> |
||
| + | |||
{| class="wikitable sortable" |
{| class="wikitable sortable" |
||
| − | |+From |
+ | |+From [[CiteRef::nemuchwala2018in]] |
!Antibiotic |
!Antibiotic |
||
!Isolates |
!Isolates |
||
Latest revision as of 13:44, 19 September 2024
- Species of Corynebacterium that causes opportunistic infections, most closely associated with hematologic stem cell transplant patients
- Clinical presentations include bacteremia, prosthetic valve endocarditis, meningitis, and peritonitis
- Essentially universally susceptible to vancomycin and linezolid
- High rates of resistance to beta lactams; may be fluoroquinolone or tetracycline susceptible1
| Antibiotic | Isolates | % Susceptible |
|---|---|---|
| Penicillin | 76 | 0 |
| Ampicillin | 76 | ND |
| Oxacillin | 76 | ND |
| Erythromycin | 76 | 11.8 |
| Clindamycin | 76 | 2.6 |
| Ciprofloxacin | 75 | 35.5 |
| Levofloxacin | 75 | ND |
| Moxifloxacin | 76 | 35.5 |
| Tetracycline | 76 | 92.1 |
| Vancomycin | 76 | 100 |
| Trimethoprim-sulfamethoxazole | 76 | 18.4 |
| Tigecycline | 76 | ND |
| Rifampin | 76 | 97.4 |
| Quinupristin-dalfopristin | 76 | 89.5 |
| Linezolid | 76 | 100 |
| Gentamicin | 76 | 81.6 |
| Daptomycin | 75 | 89.5 |
| Chloramphenicol | 75 | ND |
| Nitrofurantoin | 76 | ND |
